Beta Drugs Ltd Financial Statements

Beta Drugs Ltd Balance Sheet

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2019
Equity capital 9.61 9.61 9.61 8.65
Preference capital -- -- -- --
Reserves 82.70 59 47.50 32.30
Net worth 92.30 68.60 57.10 40.90
Minority interest
Debt 20.60 17.50 22.60 20
Deferred tax liabilities (net) -- -- -- 0.15
Total liabilities 113 86.10 79.70 61
Fixed assets 55 42.80 43.90 32.40
Intangible assets
Investments 0.78 0.78 0.35 0.35
Deferred tax asset (net) 0.68 0.65 0.17 0.29
Net working capital 39.20 31.50 29.90 24.70
Inventories 22.50 16 12.40 9.53
Inventory Days -- 50.40 49.60 --
Sundry debtors 45.20 33.90 31.90 25
Debtor days -- 106 128 --
Other current assets 16.50 13 13.10 11.80
Sundry creditors (32) (20) (16) (16)
Creditor days -- 64.40 65.70 --
Other current liabilities (13) (11) (11) (6.10)
Cash 17.30 10.40 5.39 3.30
Total assets 113 86.10 79.70 61

Invest wise with Expert advice

Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp